Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: S-EMCA

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $139 | In Stock | In Stock | |
| 5 mg | $347 | In Stock | In Stock | |
| 10 mg | $496 | In Stock | In Stock | |
| 25 mg | $795 | In Stock | In Stock | |
| 50 mg | $1,110 | - | In Stock | |
| 100 mg | $1,550 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $381 | In Stock | In Stock |
| Description | INT-777 (S-EMCA) is a potent, selective TGR5 agonist with an EC₅₀ of 0.82 μM. Following subarachnoid hemorrhage in rats, INT-777 inhibits NLRP5-ASC inflammasome-mediated neuroinflammation via the TGR3/cAMP/PKA signaling pathway. INT-777 exhibits multiple effects, including metabolic regulation, anti-inflammatory activity, cholagogue effects, and vascular protection. INT-777 can be used in research on diseases such as metabolic syndrome, non-alcoholic fatty liver disease, inflammatory bowel disease, and pulmonary arterial hypertension. |
| Targets & IC50 | CHO cells:3.44 μM (EC50), TGR5:0.82 μM (EC50), NCI-H716 cells:0.82 μM (EC50), HEK293 cells:0.36 μM (EC50), COS-1 cells:> 100 μM (EC50) |
| In vitro | Methods: Intestinal crypts isolated from wild-type and Tgr5 knockout mice were cultured into organoids. INT-777 (30μM) was added to the organoid culture medium and treated for 7 days, with organoid growth parameters (area, budding, etc.) observed. Results: INT-777 significantly promoted the growth of intestinal organoids derived from wild-type mice but had no such effect on organoids from Tgr5⁻/⁻ mice, confirming its TGR5-dependent action. [1] Methods: RAW264.7 mouse macrophages were stimulated with LPS (100 ng/mL) for 24 hours to induce M1 polarization. INT-777 (3 μM) was added 2 hours after LPS stimulation and co-incubated with cells for 24 hours. Results: Inhibited LPS-induced M1 polarization and promoted M2 polarization. [2] |
| In vivo | Methods: Adult male Sprague-Dawley rats were used. A rat subarachnoid hemorrhage (SAH) model was established via intravascular perforation. One hour after SAH, INT-777 (10, 30, 90 μg/kg) was administered intranasally, with Assess neurological function 24 hours later. Results: The 30 μg/kg dose proved most effective, significantly improving neurological function and reducing cerebral edema. [3] |
| Synonyms | S-EMCA |
| Molecular Weight | 450.65 |
| Formula | C27H46O5 |
| Cas No. | 1199796-29-6 |
| Smiles | [H][C@@]12CC[C@H]([C@H](C)C[C@H](C)C(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)[C@H](CC)[C@]2([H])C[C@H](O)CC[C@]12C |
| Relative Density. | 1.128 g/cm3 (Predicted) |
| Storage | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 50 mg/mL (110.95 mM), Sonication is recommended. DMSO: 30 mg/mL (66.57 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
Ethanol
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.